Anupam Rasayan India Ltd
NSE:ANURAS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
688.75
1 095.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ANURAS stock under the Base Case scenario is 657.4 INR. Compared to the current market price of 723.3 INR, Anupam Rasayan India Ltd is Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Anupam Rasayan India Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ANURAS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Anupam Rasayan India Ltd
Balance Sheet Decomposition
Anupam Rasayan India Ltd
Current Assets | 22.3B |
Cash & Short-Term Investments | 3.6B |
Receivables | 5.9B |
Other Current Assets | 12.8B |
Non-Current Assets | 23.8B |
Long-Term Investments | 1.3B |
PP&E | 19.7B |
Intangibles | 1.4B |
Other Non-Current Assets | 1.4B |
Current Liabilities | 13.2B |
Accounts Payable | 4.2B |
Accrued Liabilities | 17.2m |
Other Current Liabilities | 9B |
Non-Current Liabilities | 5.3B |
Long-Term Debt | 2.4B |
Other Non-Current Liabilities | 2.9B |
Earnings Waterfall
Anupam Rasayan India Ltd
Revenue
|
13.4B
INR
|
Cost of Revenue
|
-5.5B
INR
|
Gross Profit
|
7.9B
INR
|
Operating Expenses
|
-5.4B
INR
|
Operating Income
|
2.5B
INR
|
Other Expenses
|
-1.6B
INR
|
Net Income
|
939.2m
INR
|
Free Cash Flow Analysis
Anupam Rasayan India Ltd
INR | |
Free Cash Flow | INR |
In Q1 FY '25, Anupam Rasayan reported a 34% decline in revenue to INR 254 crores, primarily due to decreased agrochemical sales. Despite this, the company saw significant growth in its pharma and polymer segments, contributing 15% and 10% to revenue, respectively. The EBITDA margin dropped over 5 points to 23%. Looking forward, Anupam expects demand recovery in agrochemicals by H2 FY '25 and continued revenue growth fueled by LOIs and new contracts. The company is also investing INR 59 crores in a 9.6 MW hybrid power plant to achieve 55% green energy usage by 2027.
What is Earnings Call?
ANURAS Profitability Score
Profitability Due Diligence
Anupam Rasayan India Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Anupam Rasayan India Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
ANURAS Solvency Score
Solvency Due Diligence
Anupam Rasayan India Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Anupam Rasayan India Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ANURAS Price Targets Summary
Anupam Rasayan India Ltd
According to Wall Street analysts, the average 1-year price target for ANURAS is 720.8 INR with a low forecast of 515.1 INR and a high forecast of 1 128.75 INR.
Dividends
Current shareholder yield for ANURAS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The company is involved in the custom synthesis and manufacturing of life science related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and technologies for Indian and global customers. Its life science related specialty chemicals comprises of products related to agrochemicals, personal care, and pharmaceuticals. The company manufactures agro intermediates and agro active ingredients, such as insecticides, fungicides and herbicides and plant growth regulators. Its personal care includes anti-bacterial and ultraviolet protection intermediates and ingredients. Its pharmaceuticals include developing of intermediates and key starting materials for active pharmaceutical ingredients. Its other specialty chemicals include speciality pigments, speciality dyes, and polymer additives. The company has six manufacturing units are located in Sachin, Surat and Jhagadia, Bharuch in the state of Gujarat.
Contact
IPO
Employees
Officers
The intrinsic value of one ANURAS stock under the Base Case scenario is 657.4 INR.
Compared to the current market price of 723.3 INR, Anupam Rasayan India Ltd is Overvalued by 9%.